Private equity firms have significantly increased their ownership of methadone clinics across the U.S., acquiring over a third of these specialized facilities. Despite claims that this capital expansion modernizes care, research indicates that private equity investments have not led to increased methadone availability or the construction of new treatment centers. This trend has drawn the attention of lawmakers and federal investigations, with concerns raised about potential opposition to expanding treatment access for financial gain rather than patient well-being. AI
RANK_REASON Significant investment and regulatory scrutiny of a healthcare market segment by private equity. [lever_c_demoted from significant: ic=1 ai=0.0]
- Brown University
- Medicaid
- methadone clinics
- private equity
- RAND Corporation
- University of Pittsburgh
- U.S. Sen. Maggie Hassan
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
